Floatz logo

Eliglustat

Gaucher Disease, Non-Neuronopathic Form

Genzyme, a Sanofi CompanySmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Gaucher Disease, Non-Neuronopathic Form cohort.

Asset / SponsorPhaseRating
Cerezyme
Sanofi
Phase 4A
Velaglucerase Alfa
Baylor Research Institute
Phase 4BB
Cerezyme
Sanofi
Phase 3BB
Eliglustat
Sanofi
Phase 3BB
Miglustat
Actelion
Phase 3BB

View all 13 →

Same molecule, other indications

Eliglustat is also rated in:

Gaucher diseaseDormant
BBB
Indicative ·
76 / 100
View asset →
Gaucher Disease, Type 1Dormant
BBB
Indicative ·
76 / 100
View asset →
Gaucher diseaseDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →